Curis Inc. (CRIS): Here Are Some Research Recommendations

0
66
REV
REV

Curis Inc. (NASDAQ:CRIS) traded with an addition of $0.05 to close at $0.54 on Thursday, an upside of 9.75 percent. An average of 686,008 shares of common stock have been traded in the last five days. There was a gain of $0.0332 in the past week, and it reached a new high 4 times over the past 12 months. The last 20 days have seen an average of 1,360,442 shares traded, while the 50-day average volume stands at 851,777.

CRIS stock has decreased by -38.98% in the last month. The company shares reached their 1-month lowest point of $0.4700 on 12/27/22. With the stock rallying to its 52-week high on 01/05/22, shares of the company touched a low of $0.47 and a high of $5.27 in 52 weeks. It has reached a new high 3 times so far this year and lost -89.62% or -$4.2267 in price. In spite of this, the price is down -89.71% from the 52-week high.


Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored


Insider Transactions

CRIS stock investors should be aware that Curis Inc. (CRIS) stock had its last reported insider trading activity 332 days ago on Jan 31. In this transaction, the insider spent $9,499. President & CEO, Dentzer James E, disposed of 2,406 shares at a price of $3.18 on Jan 27. The insider now owns more than $7,651 worth of shares.

Valuation Metrics

Curis Inc. (CRIS) stock’s beta is 2.80. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 4.69, the price-to-book (PB) ratio at 0.84.

Financial Health

The quick ratio of Curis Inc. for the three months ended June 29 was 7.70, and the current ratio was 7.70, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending June 29. Its gross profit as reported stood at $10.12 million compared to revenue of $10.65 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Curis Inc.’s return on assets was -42.50%.

Earnings Surprise

For the three-month period that ended June 29, Curis Inc. had $68.84 million in cash. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$13.29 million in the quarter, while revenues of -$15.94 million were grew 16.85%. The analyst consensus anticipated Curis Inc.’s latest quarter earnings to come in at -$0.17 per share, but it turned out to be -$0.17, a 0.00% surprise. For the quarter, EBITDA amounted to -$12.47 million. Shareholders own equity worth $96.4 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Curis Inc. (CRIS) price momentum. RSI 9-day as of the close on 28 December was 40.71%, suggesting the stock is Neutral, with historical volatility in this time frame at 77.32%.

As of today, CRIS’s price is $0.4993 +6.64% or $0.0332 from its 5-day moving average. CRIS is currently trading -33.91% lower than its 20-day SMA and -48.22% lower than its 100-day SMA. However, the stock’s current price level is -27.66% below the SMA50 and -79.95% below the SMA200.

The stochastic %K and %D were 7.85% and 5.32%, respectively, and the average true range (ATR) was 0.0563. With the 14-day stochastic at 14.72% and the average true range at 0.0601, the RSI (14) stands at 37.20%. The stock has reached 0.0000 on the 9-day MACD Oscillator while the 14-day reading was at -0.0412.

Analyst Ratings

Raymond James downgraded Curis Inc. (NASDAQ: CRIS) to a a Mkt perform rating in its most recent analyst report. Previously, the stock was rated as an Outperform. The consensus rating for Curis Inc. (CRIS) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CRIS, while 2 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 3 others rate it as a “buy”.

What is CRIS’s price target for the next 12 months?

Analysts predict a range of price targets between $3.00 and $10.00, with a median target of $7.00. Taking a look at these predictions, the average price target given by analysts for Curis Inc. (CRIS) stock is $6.75.

LEAVE A REPLY

Please enter your comment!
Please enter your name here